BioSpace News Archive

Arrayjet Introduces Mercury Range of Next-Generation Microarray Printers

Arrayjet, a leading provider of inkjet liquid-handling solutions, introduced Mercury, a new core range of five instruments for ultra-low-volume liquid dispensing.

April 4, 2022
·
2 min read
Genetown

Annexon Biosciences to Participate in the 21st Annual Needham Virtual Healthcare Conference

Annexon, Inc. announced that Douglas Love, Esq., president & chief executive officer, will participate in a fireside chat at the 21st Annual Needham Virtual Healthcare Conference on Monday, April 11, 2022 at 3:45 p.m. ET.

April 4, 2022
·
1 min read
Drug Development

Curis Announces FDA Partial Clinical Hold for TakeAim Leukemia Study of Emavusertib (CA-4948)

Curis, Inc. announced that the U.S. Food and Drug Administration has placed a partial clinical hold on the Company’s TakeAim Leukemia Phase 1/2a study.

April 4, 2022
·
8 min read
Apyx Medical Corporation Announces FDA 510(k) Submission with Clinical Study Support for the Use of the Renuvion® APR Handpiece for Aesthetic Procedures to Improve Appearance of Lax Skin

Apyx Medical Corporation Announces FDA 510(k) Submission with Clinical Study Support for the Use of the Renuvion ® APR Handpiece for Aesthetic Procedures to Improve Appearance of Lax Skin.

April 4, 2022
·
5 min read
Genetown

Akili to Present at Chardan’s Prescription Digital Therapeutics Half-Day Summit

Akili Interactive today announced that management will present at Chardan’s Prescription Digital Therapeutics Half-Day Summit on Monday, April 11, 2022 at 2:00 p.m. E.T.

April 4, 2022
·
6 min read
ADC Therapeutics Receives Permanent J-Code for ZYNLONTA® (J9359) from U.S. Centers for Medicare & Medicaid Services

ADC Therapeutics SA announced today that a permanent J-code, J9359, has been issued for ZYNLONTA® by the U.S. Centers for Medicare & Medicaid Services (CMS) effective as of April 1, 2022.

April 4, 2022
·
4 min read
Business

Apollo Endosurgery Appoints Jeannette Bankes to Board of Directors

Apollo Endosurgery, Inc. today announced the appointment of Jeannette Bankes to its Board of Directors, bringing the number of board members to eight.

April 4, 2022
·
5 min read
Drug Development

Inozyme Pharma Announces Positive Preliminary Data from Phase 1/2 Clinical Trial of INZ-701 in Patients with ENPP1 Deficiency

Inozyme Pharma, Inc. today announced positive preliminary biomarker, safety, and pharmacokinetic (PK) data from the first three patients treated in the Phase 1 portion of its ongoing first-in-human Phase 1/2 clinical trial of INZ-701 in adult patients with ENPP1 Deficiency.

April 4, 2022
·
10 min read
Pharm Country

Applied Therapeutics to Present at the 43rd Annual Meeting of the Society for Inherited Metabolic Disorders

Applied Therapeutics, Inc. today announced poster presentations at the 2022 43rd Annual Meeting of the Society for Inherited Metabolic Disorders, April 10 - 13, 2022 in Orlando, Florida.

April 4, 2022
·
4 min read
Drug Development

Wave Life Sciences Announces Positive Update to Ongoing Phase 1b/2a FOCUS-C9 Study Driven by Potent, Durable Reductions of Poly(GP) with Low, Single Doses of WVE-004

Wave Life Sciences Ltd. today announced a positive update to the ongoing Phase 1b/2a FOCUS-C9 trial of WVE-004, the company’s clinical candidate for C9orf72-associated amyotrophic lateral sclerosis (C9-ALS) and frontotemporal dementia (C9-FTD).

April 4, 2022
·
13 min read